Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Park Prescription Trial

27. Juni 2017 aktualisiert von: Dr Falk Mueller-Riemenschneider, National University of Singapore
The purpose of this study is to test the effectiveness of prescribing park use (i.e., ''Park Prescription'') to insufficiently active individuals. It is hypothesized that Park Prescription will motivate the target population to increase physical activity and thereby improve their physical and mental health.

Studienübersicht

Status

Abgeschlossen

Bedingungen

Intervention / Behandlung

Detaillierte Beschreibung

BACKGROUND: There are substantial international research findings supporting the role that natural environments play in enhancing human health and the prevention of chronic diseases. Also, there is evidence highlighting the (cost-) effectiveness of prescribing physical activity to promote one's physical activity and health. However, there is a lack of methodologically rigorous studies that have looked into the effectiveness of combining these two promising approaches; i.e., physical activity prescription with a focus on the use of parks and green spaces: Park Prescription.

AIMS: This Randomized Controlled Trial (RCT) will investigate the concept of Park Prescription as a health promoting intervention for individuals. The primary objective is to investigate the effectiveness of a park prescription interventions to increase participant's time spent in moderate to vigorous physical activity (MVPA). Main secondary objectives are to assess; A) improvement in physical health (e.g., blood sugar and blood pressure) and health behaviour (e.g., sitting time); B) improvement in mental health (e.g., quality of life); 3) intervention implementation fidelity and the association with park use and perceived study participant satisfaction.

METHODOLOGY: Participants aged between 40 and 65 years will be recruited from the Singapore Population Health Community Screening Programme conducted by Alexandra Health Pte Ltd. They will be randomly assigned to one of the following two arms; 1) park prescription + participation in a weekly structured physical activity program conducted in the park, and 2) control group. Participants will be enrolled in the study for a period of 6 months. They will have to complete a baseline assessment, 3-month and 6-month follow-up. The investigators aim to recruit 80 participants in each arm, making a total of 160 study participants.

Studientyp

Interventionell

Einschreibung (Tatsächlich)

160

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

  • Singapur
      • Singapore, Singapur, 768828
        • Khoo Teck Puat Hospital

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

40 Jahre bis 65 Jahre (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Ja

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

Subjects must meet all of the inclusion criteria as listed below to participate in the study.

Study participants must:

  1. be not currently sufficiently active (less than 150 minutes per week of exercise);
  2. complete and pass the PAR-Q+*;
  3. have a blood pressure of less or equal to (<=) 139 mmHG (systolic) over less or equal to (<=) 89 mmHG (diastolic);
  4. have fasting glucose levels of less or equal to (<=) 6.0 mmol/l);
  5. be Singaporean or Permanent Residents;
  6. be able to write and read;
  7. provide informed consent.

Exclusion Criteria:

All subjects meeting any of the following exclusion criteria will be excluded from participation:

  1. pregnant women;
  2. people who have severe medical conditions prohibiting participation in physical activity as assessed by the PAR-Q (including, heart disease, lung disease, diabetes);
  3. people who have a blood pressure of >139 mmHG (systolic) over >89 mmHG (diastolic);
  4. people who have fasting glucose levels of >6.0 mmol/l);

  5. those with physical disabilities or lower limb disorders.

    • The Physical Activity Readiness Questionnaire (PAR-Q) is a self-guided, nine question screening tool that can quickly identify conditions or risk factors that require further assessment before engaging in physical activity. See: British Columbia Ministry of Health Department of National Health and Welfare: Physical Activity Readiness Questionnaire. Canada: 1992.For the current study, we are using an amended version of the PAR-Q.

The PAR-Q+ also includes an additional section to formally assess subjects' age, whether they have physical disabilities or lower limb disorders, and their physical activity status.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Verhütung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Park prescription
The participants in this group will receive a brief counseling on physical activity together with a park prescription that highlights the importance of engaging in at least 150 minutes of physical activity per week and the possibility of engaging in physical activity in the park. In addition, they are invited to join in a structured and supervised physical activity program in the park. The structured physical activity program will take place in public parks located in the participants' neighbourhood. Participants will receive text messages for reminder and registration purposes approximately once a week. Also, participants will receive a sheet to monitor their weekly physical activity, information about parks in their neighborhood, and a counseling phone call half-way through the study.
Verhalten: Park Prescription
Please refer to the information included in the arm description.
Kein Eingriff: Control
The participants in this group will not be given any park prescription or be invited to participate in the weekly program in the park. However, they will receive all the information materials provided to the experimental group after the study has ended.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Zeitfenster
Hours/week spent in Moderate to Vigorous Physical Activity (MVPA) assessed objectively with accelerometry
Zeitfenster: At 6 months follow-up
At 6 months follow-up

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Zeitfenster
Fasting glucose levels (mmol/l)
Zeitfenster: At 6 months follow-up
At 6 months follow-up
Total cholesterol (mmol/l)
Zeitfenster: At 6 months follow-up
At 6 months follow-up
LDL (mmol/l)
Zeitfenster: At 6 months follow-up
At 6 months follow-up
HDL (mmol/l)
Zeitfenster: At 6 months follow-up
At 6 months follow-up
Triglycerides (mmol/l)
Zeitfenster: At 6 months follow-up
At 6 months follow-up
Blood pressure (mmHG)
Zeitfenster: At 6 months follow-up
At 6 months follow-up
Body Mass Index (kg/m^2)
Zeitfenster: At 6 months follow-up
At 6 months follow-up
Waist circumference (cm)
Zeitfenster: At 6 months follow-up
At 6 months follow-up
Hours/week spent in Moderate to Vigorous Physical Activity (MVPA) assessed by self-report
Zeitfenster: At 6 months follow-up
At 6 months follow-up
Hours/week spent in sedentary behaviour assessed by self-report
Zeitfenster: At 6 months follow-up
At 6 months follow-up
Psychological distress assessed with Kessler-10
Zeitfenster: At 6 months follow-up
At 6 months follow-up
Physical and mental health functioning assessed with SF-12
Zeitfenster: At 6 months follow-up
At 6 months follow-up

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

National University of Singapore

Mitarbeiter

Khoo Teck Puat Hospital
National Parks Board, Singapore

Ermittler

  • Hauptermittler: Falk Mueller-Riemenschneider, Assist Prof, Saw Swee Hock School of Public Health, National University of Singapore

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Allgemeine Veröffentlichungen

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

1. Januar 2016

Primärer Abschluss (Tatsächlich)

1. Juni 2017

Studienabschluss (Tatsächlich)

1. Juni 2017

Studienanmeldedaten

Zuerst eingereicht

23. November 2015

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

24. November 2015

Zuerst gepostet (Schätzen)

26. November 2015

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

29. Juni 2017

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

27. Juni 2017

Zuletzt verifiziert

1. Juni 2017

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Schlüsselwörter

Andere Studien-ID-Nummern

  • Park Prescription Trial

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren